A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)

Detalhes bibliográficos
Autor(a) principal: Lemos, Raquel
Data de Publicação: 2022
Outros Autores: Areias-Marques, Sofia, Ferreira, Pedro, O’Brien, Philip, Beltrán-Jaunsarás, María Eugenia, Ribeiro, Gabriela, Martín, Miguel, del Monte-Millán, María, López-Tarruella, Sara, Massarrah, Tatiana, Luís-Ferreira, Fernando, Frau, Giuseppe, Venios, Stefanos, McManus, Gary, Oliveira-Maia, Albino J.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/150156
Resumo: Funding Information: AJO-M was national coordinator for Portugal of a non-interventional study (EDMS-ERI-143085581, 4.0) to characterize a Treatment-Resistant Depression Cohort in Europe, sponsored by Janssen-Cilag, Ltd (2019–2020), is recipient of a grant from Schuhfried GmBH for norming and validation of cognitive tests, and is national coordinator for Portugal of trials of psilocybin therapy for treatment-resistant depression, sponsored by Compass Pathways, Ltd (EudraCT number 2017–003288-36), and of esketamine for treatment-resistant depression, sponsored by Janssen-Cilag, Ltd (EudraCT NUMBER: 2019–002992-33). Funding Information: The FAITH project is funded under the European Commission (EC) Horizon Europe Programme, ‘H2020-EU.3.1.—SOCIETAL CHALLENGES—Health, demographic change, and well-being’. It is funded to the value €4.8 M, under the specific topic ‘SC1-DTH-01–2019—Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment’ with Grant agreement ID: 875358. The funder has no influence in the design, collection, analysis, data interpretation, or manuscript writing. Funding Information: RL is supported by an individual Scientific Employment Stimulus from Fundação para a Ciência e Tecnologia, Portugal (CEECIND/04157/2018). Publisher Copyright: © 2022, The Author(s).
id RCAP_6336d2b6aff39917344e4cffd96ebe63
oai_identifier_str oai:run.unl.pt:10362/150156
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)study protocolArtificial intelligenceCancerDepressionFederated learningQuality of lifeRemote assessmentSurvivorshipWearablesPsychiatry and Mental healthSDG 3 - Good Health and Well-beingFunding Information: AJO-M was national coordinator for Portugal of a non-interventional study (EDMS-ERI-143085581, 4.0) to characterize a Treatment-Resistant Depression Cohort in Europe, sponsored by Janssen-Cilag, Ltd (2019–2020), is recipient of a grant from Schuhfried GmBH for norming and validation of cognitive tests, and is national coordinator for Portugal of trials of psilocybin therapy for treatment-resistant depression, sponsored by Compass Pathways, Ltd (EudraCT number 2017–003288-36), and of esketamine for treatment-resistant depression, sponsored by Janssen-Cilag, Ltd (EudraCT NUMBER: 2019–002992-33). Funding Information: The FAITH project is funded under the European Commission (EC) Horizon Europe Programme, ‘H2020-EU.3.1.—SOCIETAL CHALLENGES—Health, demographic change, and well-being’. It is funded to the value €4.8 M, under the specific topic ‘SC1-DTH-01–2019—Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment’ with Grant agreement ID: 875358. The funder has no influence in the design, collection, analysis, data interpretation, or manuscript writing. Funding Information: RL is supported by an individual Scientific Employment Stimulus from Fundação para a Ciência e Tecnologia, Portugal (CEECIND/04157/2018). Publisher Copyright: © 2022, The Author(s).Background: Depression is a common condition among cancer patients, across several points in the disease trajectory. Although presenting higher prevalence rates than the general population, it is often not reported or remains unnoticed. Moreover, somatic symptoms of depression are common in the oncological context and should not be dismissed as a general symptom of cancer. It becomes even more challenging to track psychological distress in the period after the treatment, where connection with the healthcare system typically becomes sporadic. The main goal of the FAITH project is to remotely identify and predict depressive symptoms in cancer survivors, based on a federated machine learning (ML) approach, towards optimization of privacy. Methods: FAITH will remotely analyse depression markers, predicting their negative trends. These markers will be treated in distinct categories, namely nutrition, sleep, activity and voice, assessed in part through wearable technologies. The study will include 300 patients who have had a previous diagnosis of breast or lung cancer and will be recruited 1 to 5 years after the end of primary cancer. The study will be organized as a 12-month longitudinal prospective observational cohort study, with monthly assessments to evaluate depression symptoms and quality of life among cancer survivors. The primary endpoint is the severity of depressive symptoms as measured by the Hamilton Depression Rating Scale (Ham-D) at months 3, 6, 9 and 12. Secondary outcomes include self-reported anxiety and depression symptoms (HADS scale), and perceived quality of life (EORTC questionnaires), at baseline and monthly. Based on the predictive models gathered during the study, FAITH will also aim at further developing a conceptual federated learning framework, enabling to build machine learning models for the prediction and monitoring of depression without direct access to user’s personal data. Discussion: Improvements in the objectivity of psychiatric assessment are necessary. Wearable technologies can provide potential indicators of depression and anxiety and be used for biofeedback. If the FAITH application is effective, it will provide healthcare systems with a novel and innovative method to screen depressive symptoms in oncological settings. Trial registration: Trial ID: ISRCTN10423782. Date registered: 21/03/2022.Faculdade de Ciências e Tecnologia (FCT)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNLemos, RaquelAreias-Marques, SofiaFerreira, PedroO’Brien, PhilipBeltrán-Jaunsarás, María EugeniaRibeiro, GabrielaMartín, Migueldel Monte-Millán, MaríaLópez-Tarruella, SaraMassarrah, TatianaLuís-Ferreira, FernandoFrau, GiuseppeVenios, StefanosMcManus, GaryOliveira-Maia, Albino J.2023-03-07T22:27:42Z2022-122022-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/150156eng1471-244XPURE: 53599221https://doi.org/10.1186/s12888-022-04446-5info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:32:00Zoai:run.unl.pt:10362/150156Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:53:58.580298Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
study protocol
title A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
spellingShingle A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
Lemos, Raquel
Artificial intelligence
Cancer
Depression
Federated learning
Quality of life
Remote assessment
Survivorship
Wearables
Psychiatry and Mental health
SDG 3 - Good Health and Well-being
title_short A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
title_full A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
title_fullStr A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
title_full_unstemmed A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
title_sort A prospective observational study for a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment (FAITH)
author Lemos, Raquel
author_facet Lemos, Raquel
Areias-Marques, Sofia
Ferreira, Pedro
O’Brien, Philip
Beltrán-Jaunsarás, María Eugenia
Ribeiro, Gabriela
Martín, Miguel
del Monte-Millán, María
López-Tarruella, Sara
Massarrah, Tatiana
Luís-Ferreira, Fernando
Frau, Giuseppe
Venios, Stefanos
McManus, Gary
Oliveira-Maia, Albino J.
author_role author
author2 Areias-Marques, Sofia
Ferreira, Pedro
O’Brien, Philip
Beltrán-Jaunsarás, María Eugenia
Ribeiro, Gabriela
Martín, Miguel
del Monte-Millán, María
López-Tarruella, Sara
Massarrah, Tatiana
Luís-Ferreira, Fernando
Frau, Giuseppe
Venios, Stefanos
McManus, Gary
Oliveira-Maia, Albino J.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Faculdade de Ciências e Tecnologia (FCT)
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Lemos, Raquel
Areias-Marques, Sofia
Ferreira, Pedro
O’Brien, Philip
Beltrán-Jaunsarás, María Eugenia
Ribeiro, Gabriela
Martín, Miguel
del Monte-Millán, María
López-Tarruella, Sara
Massarrah, Tatiana
Luís-Ferreira, Fernando
Frau, Giuseppe
Venios, Stefanos
McManus, Gary
Oliveira-Maia, Albino J.
dc.subject.por.fl_str_mv Artificial intelligence
Cancer
Depression
Federated learning
Quality of life
Remote assessment
Survivorship
Wearables
Psychiatry and Mental health
SDG 3 - Good Health and Well-being
topic Artificial intelligence
Cancer
Depression
Federated learning
Quality of life
Remote assessment
Survivorship
Wearables
Psychiatry and Mental health
SDG 3 - Good Health and Well-being
description Funding Information: AJO-M was national coordinator for Portugal of a non-interventional study (EDMS-ERI-143085581, 4.0) to characterize a Treatment-Resistant Depression Cohort in Europe, sponsored by Janssen-Cilag, Ltd (2019–2020), is recipient of a grant from Schuhfried GmBH for norming and validation of cognitive tests, and is national coordinator for Portugal of trials of psilocybin therapy for treatment-resistant depression, sponsored by Compass Pathways, Ltd (EudraCT number 2017–003288-36), and of esketamine for treatment-resistant depression, sponsored by Janssen-Cilag, Ltd (EudraCT NUMBER: 2019–002992-33). Funding Information: The FAITH project is funded under the European Commission (EC) Horizon Europe Programme, ‘H2020-EU.3.1.—SOCIETAL CHALLENGES—Health, demographic change, and well-being’. It is funded to the value €4.8 M, under the specific topic ‘SC1-DTH-01–2019—Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment’ with Grant agreement ID: 875358. The funder has no influence in the design, collection, analysis, data interpretation, or manuscript writing. Funding Information: RL is supported by an individual Scientific Employment Stimulus from Fundação para a Ciência e Tecnologia, Portugal (CEECIND/04157/2018). Publisher Copyright: © 2022, The Author(s).
publishDate 2022
dc.date.none.fl_str_mv 2022-12
2022-12-01T00:00:00Z
2023-03-07T22:27:42Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/150156
url http://hdl.handle.net/10362/150156
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1471-244X
PURE: 53599221
https://doi.org/10.1186/s12888-022-04446-5
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138129822613504